Patents by Inventor Tobias Wunberg

Tobias Wunberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted thiophenes
    Publication number: 20070099929
    Abstract: The invention relates to substituted thiophenes and processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular for hepatitis C viruses.
    Type: Application
    Filed: June 16, 2006
    Publication date: May 3, 2007
    Applicant: AiCuris GmbH & Co. KG
    Inventors: Kai Thede, Tobias Wunberg, Timothy Lowinger, Diana Koletzki, Andreas Urban, Judith Baumeister, Kerstin Henninger
  • Substituted dihydroquinazolines
    Patent number: 7196086
    Abstract: The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.
    Type: Grant
    Filed: April 26, 2004
    Date of Patent: March 27, 2007
    Assignee: Bayer HealthCare AG
    Inventors: Tobias Wunberg, Judith Baumeister, Ulrich Betz, Mario Jeske, Thomas Lampe, Susanne Nikolic, Jürgen Reefschläger, Rudolf Schohe-Loop, Frank Süssmeier, Holger Zimmermann, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Jörg Keldenich, Dieter Lang, Peter Nell
  • 2-(3-Phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses
    Publication number: 20070066622
    Abstract: The invention relates to dihydroquinazolines and methods for the production thereof, the use thereof in the treatment and/or prophylaxis of diseases, in addition to the use thereof in the production of medicaments in the treatment and/or prophylaxis of diseases, especially for use as anti-viral agents, especially against cytomegalo viruses.
    Type: Application
    Filed: January 29, 2004
    Publication date: March 22, 2007
    Inventors: Tobias Wunberg, Judith Baumeister, Ulrich Betz, Mario Jeske, Gerald Kleymann, Thomas Lampe, Susanne Nikolic, Jurgen Reefshlager, Rudolf Schohe-Loop, Frank Submeier, Holger Zimmermann, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Jorg Keldenich, Thomas Kramer, Peter Nell, Tse-I Lin
  • Method for inhibiting the replication of herpes viruses
    Publication number: 20070004735
    Abstract: The invention relates to a method for inhibiting the replication of herpesviruses, to methods for identifying compounds which inhibit the replication of herpesviruses using this method, to compounds having activity against herpesviruses, to methods for their preparation and to their use for producing medicaments for the treatment of herpes infections.
    Type: Application
    Filed: December 24, 2003
    Publication date: January 4, 2007
    Inventors: Ulrich Betz, Guy Hewlett, Gerald Kleymann, Thomas Lampe, Tse-I Lin, Susanne Nikolic, Jurgen Reefshlager, Tobias Wunberg, Holger Zimmerman, Franz Zumpe, Wolfgang Bender, Kerstin Henninger, Axel Jensen, Jorg Keldenich, Rudolf Schohe-Loop
  • Substituted quinazolines as antiviral agents, especially against cytomegaloviruses
    Publication number: 20060235032
    Abstract: The invention relates to substituted quinazolines and to methods for the production thereof, in addition to the use thereof in the production of medicaments for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.
    Type: Application
    Filed: October 25, 2003
    Publication date: October 19, 2006
    Inventors: Tobias Wunberg, Judith Baumeister, Mario Jeske, Susanne Nikolic, Frank Submeier, Holger Zimmermann, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Jorg Keldenich, Dieter Lang, Tse-I Lin
  • Arylsulfonamides as antiviral agents
    Patent number: 7115612
    Abstract: The present invention relates to novel sulphonamides of the general formula (I) in which the substituents R1, R2, R3, R4 and A and X are as defined in claim 1 and other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: October 3, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jörg Keldenich, Armin Kern, Siegfried Raddatz, Jürgen Reefschläger, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Hetrocyclic aryl sulphonamides
    Patent number: 7115636
    Abstract: The invention relates to novel sulfonamides of general formula (I) where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: October 3, 2006
    Assignee: Bayer Healthcare AG
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jörg Keldenich, Armin Kern, Siegfried Raddatz, Jürgen Reefschläger, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Hetrocyclic aryl sulphonamides
    Publication number: 20050085549
    Abstract: The invention relates to novel sulfonamides of general formula (I) where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.
    Type: Application
    Filed: July 24, 2002
    Publication date: April 21, 2005
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jorg Keldenich, Armin Kern, Siegfried Raddatz, Jurgen Reefschlager, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Substituted dihydroquinazolines
    Publication number: 20050065160
    Abstract: The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.
    Type: Application
    Filed: April 26, 2004
    Publication date: March 24, 2005
    Applicant: Bayer HealthCare AG
    Inventors: Tobias Wunberg, Judith Baumeister, Ulrich Betz, Mario Jeske, Thomas Lampe, Susanne Nikolic, Jurgen Reefschlager, Rudolf Schohe-Loop, Frank Sussmeier, Holger Zimmermann, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Jorg Keldenich, Dieter Lang, Peter Nell
  • Pyridazinone
    Publication number: 20050059658
    Abstract: The invention relates to novel compounds, to a method for the production of said compounds and to the use thereof as medicaments, more particularly as antiviral agents, especially against cytomegalovirus.
    Type: Application
    Filed: June 17, 2002
    Publication date: March 17, 2005
    Inventors: Tobias Wunberg, Ulrich Betz, Sabine Hallenberger, Gerald Kleymann, Thomas Lampe, Susanne Nikolic, Jurgen Reefschlager, Franz Zumpe, Marcus Bauser, Wolfgang Bender, Rolf Grosser, Kerstin Henninger, Guy Hewlett, Axel Jensen, Jorg Keldenich, Holger Zimmermann
  • Arylsulfonamides as antiviral agents
    Publication number: 20040176374
    Abstract: The present invention relates to novel sulphonamides of the general formula (I) 1
    Type: Application
    Filed: April 12, 2004
    Publication date: September 9, 2004
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jorg Keldenich, Armin Kern, Siegfried Raddatz, Jurgen Reefschlager, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Substituted tetrahydropyrane derivatives, method for producing same, their use as medicine or diagnostic agent, as well as medicine containing same
    Patent number: 6756489
    Abstract: Substituted tetrahydropyran derivatives, processes for their preparation, their use as a pharmaceutical or diagnostic, and pharmaceutical comprising them. The invention relates to compounds of the formula I in which the radicals R1, R2, R3, R4, R5 and X have the meaning mentioned in the description, a process for the preparation of the compounds of the formula I on a solid phase, and their use as pharmaceuticals.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: June 29, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Wolfgang Schmidt, Stephan Henke, Horst Kunz, Christopher Kallus, Till Opatz, Tobias Wunberg